Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients

Prognostic Factors and Clinical Considerations for Iron Chelation Therapy in Myelodysplastic Syndrome Patients

Sarah Parisi,1 Carlo Finelli2 1IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seràgnoli”, Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy; 2IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologi...

Full description

Bibliographic Details
Main Authors: Parisi S, Finelli C
Format: Article
Language:English
Published: Dove Medical Press 2021-12-01
Series:Journal of Blood Medicine
Subjects:
iron overload
myelodysplastic syndrome
iron chelation therapy
hepcidin
Online Access:https://www.dovepress.com/prognostic-factors-and-clinical-considerations-for-iron-chelation-ther-peer-reviewed-fulltext-article-JBM

Internet

https://www.dovepress.com/prognostic-factors-and-clinical-considerations-for-iron-chelation-ther-peer-reviewed-fulltext-article-JBM

Similar Items